JPH0235758B2 - - Google Patents
Info
- Publication number
- JPH0235758B2 JPH0235758B2 JP57199147A JP19914782A JPH0235758B2 JP H0235758 B2 JPH0235758 B2 JP H0235758B2 JP 57199147 A JP57199147 A JP 57199147A JP 19914782 A JP19914782 A JP 19914782A JP H0235758 B2 JPH0235758 B2 JP H0235758B2
- Authority
- JP
- Japan
- Prior art keywords
- group
- carbon atoms
- formula
- general formula
- compounds
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 125000004432 carbon atom Chemical group C* 0.000 claims description 21
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical group CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 claims description 18
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 16
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 14
- 238000000034 method Methods 0.000 claims description 14
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 claims description 12
- 239000002904 solvent Substances 0.000 claims description 10
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims description 8
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 6
- 125000003342 alkenyl group Chemical group 0.000 claims description 6
- 125000000217 alkyl group Chemical group 0.000 claims description 6
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 claims description 5
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 5
- 230000007935 neutral effect Effects 0.000 claims description 5
- 229940109171 rifamycin sv Drugs 0.000 claims description 5
- 125000004573 morpholin-4-yl group Chemical group N1(CCOCC1)* 0.000 claims description 4
- 125000004433 nitrogen atom Chemical group N* 0.000 claims description 4
- 150000003512 tertiary amines Chemical class 0.000 claims description 4
- 125000003710 aryl alkyl group Chemical group 0.000 claims description 3
- 125000004122 cyclic group Chemical group 0.000 claims description 3
- 125000000753 cycloalkyl group Chemical group 0.000 claims description 3
- 229910052757 nitrogen Inorganic materials 0.000 claims description 3
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 3
- WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 claims description 2
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 claims description 2
- 238000004519 manufacturing process Methods 0.000 claims 1
- 150000001875 compounds Chemical class 0.000 description 29
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 12
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 12
- 239000000243 solution Substances 0.000 description 12
- 229910052739 hydrogen Inorganic materials 0.000 description 9
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 6
- HJYYPODYNSCCOU-ODRIEIDWSA-N rifamycin SV Chemical class OC1=C(C(O)=C2C)C3=C(O)C=C1NC(=O)\C(C)=C/C=C/[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@H](C)[C@@H](OC)\C=C\O[C@@]1(C)OC2=C3C1=O HJYYPODYNSCCOU-ODRIEIDWSA-N 0.000 description 6
- NWZSZGALRFJKBT-KNIFDHDWSA-N (2s)-2,6-diaminohexanoic acid;(2s)-2-hydroxybutanedioic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O.NCCCC[C@H](N)C(O)=O NWZSZGALRFJKBT-KNIFDHDWSA-N 0.000 description 4
- AZQWKYJCGOJGHM-UHFFFAOYSA-N 1,4-benzoquinone Chemical compound O=C1C=CC(=O)C=C1 AZQWKYJCGOJGHM-UHFFFAOYSA-N 0.000 description 4
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 4
- IKDUDTNKRLTJSI-UHFFFAOYSA-N hydrazine monohydrate Substances O.NN IKDUDTNKRLTJSI-UHFFFAOYSA-N 0.000 description 4
- NUJOXMJBOLGQSY-UHFFFAOYSA-N manganese dioxide Chemical compound O=[Mn]=O NUJOXMJBOLGQSY-UHFFFAOYSA-N 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- SCYULBFZEHDVBN-UHFFFAOYSA-N 1,1-Dichloroethane Chemical compound CC(Cl)Cl SCYULBFZEHDVBN-UHFFFAOYSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 150000007857 hydrazones Chemical class 0.000 description 3
- 230000003647 oxidation Effects 0.000 description 3
- 238000007254 oxidation reaction Methods 0.000 description 3
- -1 potassium ferricyanide Chemical compound 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- 239000012043 crude product Substances 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 239000012074 organic phase Substances 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- BBNQHOMJRFAQBN-UPZFVJMDSA-N 3-formylrifamycin sv Chemical compound OC1=C(C(O)=C2C)C3=C(O)C(C=O)=C1NC(=O)\C(C)=C/C=C/[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@H](C)[C@@H](OC)\C=C\O[C@@]1(C)OC2=C3C1=O BBNQHOMJRFAQBN-UPZFVJMDSA-N 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 241001676573 Minium Species 0.000 description 1
- 241000186359 Mycobacterium Species 0.000 description 1
- 241000187479 Mycobacterium tuberculosis Species 0.000 description 1
- HJYYPODYNSCCOU-ZDHWWVNNSA-N Rifamycin SV Natural products COC1C=COC2(C)Oc3c(C)c(O)c4c(O)c(NC(=O)C(=C/C=C/C(C)C(O)C(C)C(O)C(C)C(OC(=O)C)C1C)C)cc(O)c4c3C2=O HJYYPODYNSCCOU-ZDHWWVNNSA-N 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 150000004945 aromatic hydrocarbons Chemical class 0.000 description 1
- JQXXHWHPUNPDRT-YOPQJBRCSA-N chembl1332716 Chemical compound O([C@](C1=O)(C)O\C=C/[C@@H]([C@H]([C@@H](OC(C)=O)[C@H](C)[C@H](O)[C@H](C)[C@@H](O)[C@@H](C)/C=C\C=C(C)/C(=O)NC=2C(O)=C3C(O)=C4C)C)OC)C4=C1C3=C(O)C=2\C=N\N1CCN(C)CC1 JQXXHWHPUNPDRT-YOPQJBRCSA-N 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 230000006196 deacetylation Effects 0.000 description 1
- 238000003381 deacetylation reaction Methods 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 125000004634 hexahydroazepinyl group Chemical group N1(CCCCCC1)* 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 125000005936 piperidyl group Chemical group 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 125000002112 pyrrolidino group Chemical group [*]N1C([H])([H])C([H])([H])C([H])([H])C1([H])[H] 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 229960001225 rifampicin Drugs 0.000 description 1
- 238000013207 serial dilution Methods 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000004809 thin layer chromatography Methods 0.000 description 1
- 201000008827 tuberculosis Diseases 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
- C07D493/08—Bridged systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/08—Bridged systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB8134549 | 1981-11-17 | ||
| GB8134549 | 1981-11-17 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS5892682A JPS5892682A (ja) | 1983-06-02 |
| JPH0235758B2 true JPH0235758B2 (ru) | 1990-08-13 |
Family
ID=10525927
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP57199147A Granted JPS5892682A (ja) | 1981-11-17 | 1982-11-15 | 新規なアジノリフアマイシン類 |
Country Status (32)
| Country | Link |
|---|---|
| US (1) | US4447432A (ru) |
| JP (1) | JPS5892682A (ru) |
| KR (1) | KR880001284B1 (ru) |
| AT (1) | AT376222B (ru) |
| AU (1) | AU553727B2 (ru) |
| BE (1) | BE895020A (ru) |
| CA (1) | CA1205074A (ru) |
| CH (1) | CH657619A5 (ru) |
| CS (1) | CS235972B2 (ru) |
| DE (1) | DE3241764A1 (ru) |
| DK (1) | DK157873C (ru) |
| ES (1) | ES517153A0 (ru) |
| FI (1) | FI73436C (ru) |
| FR (1) | FR2516514A1 (ru) |
| GB (2) | GB2110677B (ru) |
| GR (1) | GR76790B (ru) |
| HK (1) | HK74687A (ru) |
| HU (1) | HU186160B (ru) |
| IE (1) | IE54153B1 (ru) |
| IL (1) | IL67263A (ru) |
| IT (1) | IT1224111B (ru) |
| MX (1) | MX157130A (ru) |
| NL (1) | NL8204330A (ru) |
| NO (1) | NO167290C (ru) |
| NZ (1) | NZ202495A (ru) |
| PH (1) | PH17897A (ru) |
| PT (1) | PT75850A (ru) |
| SE (1) | SE453506B (ru) |
| SG (1) | SG34787G (ru) |
| SU (1) | SU1378783A3 (ru) |
| YU (1) | YU44034B (ru) |
| ZA (1) | ZA828387B (ru) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1201963B (it) * | 1983-03-24 | 1989-02-02 | Prodotti Antibiotici Spa | Derivati delle rifamicine e procedimento per la loro preparazione |
| GB8308166D0 (en) * | 1983-03-24 | 1983-05-05 | Erba Farmitalia | Preparation of azinomethyl-rifamycins |
| US4560509A (en) * | 1983-11-16 | 1985-12-24 | Eli Lilly And Company | Antibiotic A39079 factor S-1 |
| GB8408924D0 (en) * | 1984-04-06 | 1984-05-16 | Dobfar Spa | 3-azinomethyl rifamycins |
| US4956373A (en) * | 1989-01-31 | 1990-09-11 | Farmitalia Carlo Erba S.R.L | Pharmaceutical composition comprising 3-(N-piperidinomethyl-azino) methylrifamycin S as active ingredient |
| JPH02215716A (ja) * | 1989-02-08 | 1990-08-28 | Farmitalia Carlo Erba Spa | ３―（ｎ―ピペリジノメチル―アジノ）メチルリファマイシンｓを活性成分として含有する薬剤組成物 |
| JP3202960B2 (ja) * | 1998-02-17 | 2001-08-27 | 大塚化学株式会社 | ハロゲン化剤及び水酸基のハロゲン化方法 |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5128640A (ru) * | 1974-09-03 | 1976-03-11 | Matsushita Electric Ind Co Ltd |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR208F (ru) * | 1964-07-31 | |||
| GB1336399A (en) * | 1971-06-24 | 1973-11-07 | Lepetit Spa | 3-formylrifamycin sv derivatives |
| BE794298A (fr) * | 1972-01-19 | 1973-05-16 | Lepetit Spa | Derives d'imidazole de rifamycine et leur preparation |
| AR205434A1 (es) * | 1972-03-27 | 1976-05-07 | Lepetit Spa | Proceso para la preparacion de 3-acilhidrazonometil rifamicinas sv |
| CH605974A5 (en) * | 1973-09-28 | 1978-10-13 | Ciba Geigy Ag | 3-(4-Substd.-1-piperazinyl) rifamycin S and SV derivs |
| GB1478563A (en) * | 1975-03-05 | 1977-07-06 | Lepetit Spa | Rifamycin derivatives |
| IT1135270B (it) * | 1980-04-12 | 1986-08-20 | Erba Farmitalia | 3-amidino-ansamicine |
-
1982
- 1982-09-29 US US06/427,467 patent/US4447432A/en not_active Expired - Lifetime
- 1982-11-05 ES ES517153A patent/ES517153A0/es active Granted
- 1982-11-09 NL NL8204330A patent/NL8204330A/nl not_active Application Discontinuation
- 1982-11-11 DE DE19823241764 patent/DE3241764A1/de active Granted
- 1982-11-12 FI FI823902A patent/FI73436C/fi not_active IP Right Cessation
- 1982-11-12 CA CA000415479A patent/CA1205074A/en not_active Expired
- 1982-11-12 IT IT24224/82A patent/IT1224111B/it active
- 1982-11-12 AU AU90413/82A patent/AU553727B2/en not_active Ceased
- 1982-11-12 SU SU823511202A patent/SU1378783A3/ru active
- 1982-11-12 MX MX195153A patent/MX157130A/es unknown
- 1982-11-15 JP JP57199147A patent/JPS5892682A/ja active Granted
- 1982-11-15 AT AT0414982A patent/AT376222B/de not_active IP Right Cessation
- 1982-11-15 GB GB08232608A patent/GB2110677B/en not_active Expired
- 1982-11-15 PH PH28138A patent/PH17897A/en unknown
- 1982-11-15 CS CS828107A patent/CS235972B2/cs unknown
- 1982-11-15 SE SE8206499A patent/SE453506B/sv not_active IP Right Cessation
- 1982-11-15 NO NO823812A patent/NO167290C/no unknown
- 1982-11-15 GR GR69817A patent/GR76790B/el unknown
- 1982-11-15 GB GB08232609A patent/GB2119365B/en not_active Expired
- 1982-11-15 ZA ZA828387A patent/ZA828387B/xx unknown
- 1982-11-15 YU YU2554/82A patent/YU44034B/xx unknown
- 1982-11-15 CH CH6643/82A patent/CH657619A5/it not_active IP Right Cessation
- 1982-11-15 PT PT75851A patent/PT75850A/pt not_active IP Right Cessation
- 1982-11-15 NZ NZ202495A patent/NZ202495A/en unknown
- 1982-11-15 IE IE2725/82A patent/IE54153B1/en unknown
- 1982-11-15 DK DK507282A patent/DK157873C/da not_active IP Right Cessation
- 1982-11-15 FR FR8219046A patent/FR2516514A1/fr active Granted
- 1982-11-15 IL IL67263A patent/IL67263A/xx unknown
- 1982-11-16 BE BE0/209480A patent/BE895020A/fr not_active IP Right Cessation
- 1982-11-16 HU HU823673A patent/HU186160B/hu not_active IP Right Cessation
- 1982-11-16 KR KR8205164A patent/KR880001284B1/ko not_active IP Right Cessation
-
1987
- 1987-04-14 SG SG347/87A patent/SG34787G/en unknown
- 1987-10-15 HK HK746/87A patent/HK74687A/xx unknown
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5128640A (ru) * | 1974-09-03 | 1976-03-11 | Matsushita Electric Ind Co Ltd |
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IE51204B1 (en) | Imidazo-rifamycin derivatives | |
| JPH0235758B2 (ru) | ||
| US4174320A (en) | Process for the preparation of rifampicin | |
| US4965261A (en) | Substituted benzoxazinorifamycin derivative and antibacterial agent containing the same | |
| US3647786A (en) | Preparation of cephalosporin sulfoxides | |
| IE42997B1 (en) | Novel rifamycin compounds | |
| IE51144B1 (en) | Rifamycin derivatives | |
| US3625960A (en) | Rifamycin sv derivatives | |
| CA1213278A (en) | 3-azinomethyl rifamycins | |
| US3597421A (en) | Cephalosporin sulfoxides | |
| Koster et al. | Chlorination of the cephem dihydrothiazine ring. Factors influencing C-2 substitution vs. degradation to isothiazoles1 | |
| JPH0357915B2 (ru) | ||
| EP0005140B1 (en) | Novel 4-desoxy-thiazolo (5,4-c) rifamycin derivatives and a process for preparing them | |
| JPS6335579A (ja) | 含硫ベンゾキサジノリフアマイシン誘導体 | |
| Sheehan et al. | Synthesis and reactions of 7-hydrazonocephalosporanates | |
| KR820001609B1 (ko) | 4-데속시-티아졸로[5, 4-c]리파마이신 유도체의 제조방법 | |
| US4046759A (en) | Penicillin esters | |
| SU791244A3 (ru) | Способ получени оксазолиноазетидиновых соединений | |
| JP2780807B2 (ja) | 置換ベンゾキサジノリファマイシン誘導体 | |
| FI63414B (fi) | Foerfarande foer framstaellning av terapeutiskt anvaendbara 7-cylamido-3-acetoximetyl-2-(eller 3-)-cefem-4-karboxylsyra deivat | |
| EP0551953B1 (en) | 17-(Pyridazine-N-oxide)-substituted steroidal compounds active on the cardiovascular system | |
| GB2082169A (en) | Hydrazono rifamycins | |
| HU183983B (en) | Process for preparing brominated hydroxyimino-e-homo-eburnan derivatives | |
| GB2069485A (en) | Rifamycin derivatives | |
| KR20000051062A (ko) | 7-아미노데스아세톡시세팔로스포린산 유도체의 제조방법 |